Cannabix Technologies (Cannabix Technologies) 3-Year EBITDA Growth Rate : 17.20% (As of Jan. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Cannabix Technologies 3-Year EBITDA Growth Rate?

Cannabix Technologies's EBITDA per Share for the three months ended in Jan. 2024 was $-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 17.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -1.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cannabix Technologies was 27.50% per year. The lowest was -75.80% per year. And the median was 0.70% per year.

Competitive Comparison of Cannabix Technologies's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Cannabix Technologies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabix Technologies's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cannabix Technologies's 3-Year EBITDA Growth Rate falls into.

Cannabix Technologies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cannabix Technologies (OTCPK:BLOZF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cannabix Technologies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cannabix Technologies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabix Technologies (Cannabix Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cannabix Technologies Inc (OTCPK:BLOZF) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

8CT:Germany BLO:Canada

Address

501-3292 Production Way, Burnaby, BC, CAN, V5A 4R4

Website

https://www.cannabixtechnologies.com

Cannabix Technologies Inc is in the development of marijuana breathalyzer. It is developing breath testing technologies that can be used at the point of care to detect recent use of marijuana. It is also developing its technology to help employers, law enforcement, government and the public, when marijuana is becoming legal for recreational and medicinal use in many jurisdictions globally. The FAIMS device is designed to operate both independently or coupled in tandem directly to a mass spectrometer, used in forensic labs. The THC Breath Analyzer is a point of care breath testing tool for the rapid detection of recent cannabis use.

Cannabix Technologies (Cannabix Technologies) Headlines

From GuruFocus

US and Canadian Officials Scramble to Solve Marijuana-Impaired Driving Issue -- CFN Media

By Marketwired Marketwired • 04-17-2018

Recent Vermont Legislation Highlights Hurdles Surrounding Cannabis Impairment Testing -- CFN Media

By Marketwired Marketwired • 06-05-2018

Cannabis Users Drive High, and Crashes Are on the Rise-- CFN Media

By Marketwired Marketwired • 12-15-2018

Cannabix Technologies Provides Update on THC Breath Analyzer Development and Testing

By Marketwired Marketwired • 08-13-2020

New Canadian Study Shows Widespread Drugged Driving -- CFN Media

By Marketwired Marketwired • 08-14-2018